Beyond ASX shares: Bell Asset tips three international shares as buys

International share markets offer some compelling investment opportunities.

There are plenty of quality, high performing ASX shares.

Like online luxury goods retailer Cettire Ltd (ASX: CTT). The Cettire share price tops the leader's board of big gainers on the All Ordinaries Index (ASX: XAO) in 2021, up a remarkable 618% year-to-date.

With that said, ASX shares make up only some 2% of the total global share market. So it's worth considering looking beyond our shores to potential opportunities overseas.

But don't just take my word for it.

According to The Motley Fool's own Scott Phillips:

Investing internationally delivers tremendous portfolio diversification benefits and brings a world of opportunities to your investment doorstep.

And indeed, while the diversification benefits are very important, I actually think they run second to the sheer investment opportunities that exist overseas. Some of the very best companies on this blue and green planet aren't on the ASX – so why would we limit ourselves to just our home market?

With that in mind, we take a look at 3 small-cap international shares tipped during yesterday's 'Bell Asset Management – Global equities market update and outlook for 2022' webinar.

Best asx small cap stock global opportunity

Image source: Getty Images

Looking beyond ASX shares

Ned Bell, Bell Asset Management's chief investment officer, spearheaded the webinar.

On the buy side for the asset manager, he named 3 international shares that have come off their highs to be trading within Bell Asset's buy level. Namely: Amedisys Inc (NASDAQ: AMED), GN Store Nord A/S (CPH: GN) and Intertek Group plc (LON: ITRK).

According to Bell:

GN, Intertek and Amedisys… are 3 names that we've been watching. We've owned Intertek before… They've been a little bit too expensive. We've been waiting from some earnings uncertainty and volatility to give us a buying opportunity. And that's exactly what's happened.

Those 3 names have come off their highs. They've got down to our buy levels, and that's what triggered the buy here…

What these stocks all have in common, Bell added, "is that we've been patient on getting into them. And we think, looking ahead to the next 12-24 months, you're going to get some P/E [price to earnings ratio] re-ratings."

If you've been focused primarily on ASX shares you may not be familiar with these names.

In a nutshell:

Amedisys is a US healthcare company with a market cap of approximately US$5.4 billion. Shares finished up 4% yesterday but remain down 40% over the past 6 months.

GN is a Danish manufacturer of hearing aids and headsets. The GN share price finished up 1% yesterday and is down 24% over the past 6 months.

Intertek is a London-based global quality assurance provider. Shares finished flat yesterday and are down 20% over the past 6 months.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Cettire Limited. The Motley Fool Australia has recommended Cettire Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on International Stock News

a person holds their head in their hands as they slump forward over a laptop computer which features a thick red downward arrow zigzagging downwards across the screen.
International Stock News

3 catalysts that could send Nvidia shares below $120 in the next 12 months

Nvidia shares could be down 50% from their peak within the year. These three catalysts could be the reason why.

Read more »

IPO spelt out on a laptop with a red and green bar chart underneath.
IPOs

Anthropic hits the market. Was it enough to distract investors from a bruised AI sector and Nvidia's scandal?

Was the biggest IPO in US history enough to re-energise the AI trade?

Read more »

Three businessmen stand in silhouette against a window of an office with papers displaying graphs and office documents on a desk in the foreground.
International Stock News

3 Berkshire 13F moves you may have missed while watching Anthropic and Nvidia

Greg Abel’s bets are worth paying attention to.

Read more »

CEO leading a board meeting.
International Stock News

Forget the headline numbers, Nvidia's future rests on this one crucial decision

This decision carries more weight for Nvidia than every earnings beat of the past three years combined.

Read more »

IPO written in purple on blocks on top of each other in the air.
IPOs

Anthropic IPO: Are 5 types of shares too many?

Anthropic is going for a very unusual setup.

Read more »

A cute little kid in a suit pulls a shocked face as he talks on his smartphone.
International Stock News

Anthropic IPO: Why you might get a call offering shares

Anthropic's IPO is coming to Australia.

Read more »

An arrow going upwards with a road sign saying 'IPO ahead'.
International Stock News

Anthropic IPO? 3 reasons why I won't be buying in

Anthropic's IPO will be a blockbuster, but I'll be watching from the sidelines.

Read more »

A rocket blasts off into space with planet behind it.
Opinions

SpaceX shares are flying. Here's the price I'd wait for

SpaceX is on my watchlist, but I’m staying patient.

Read more »